- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Am J Infect Control. 2015 Oct 27. pii: S0196-6553(15)00941-4. doi: 10.1016/j.ajic.2015.08.024. [Epub ahead of print]
The acceptable duration between occupational exposure to hepatitis B virus and hepatitis B immunoglobulin injection: Results from a Korean nationwide, multicenter study.
Chang HH1, Lee WK1, Moon C2, Choi WS3, Yoon HJ4, Kim J5, Ryu SY6, Kim HA6, Jo YM7, Kwon KT8, Kim HI8, Sohn JW9, Yoon YK9, Jung SI10, Park KH10, Kwon HH11, Lee MS12, Kim YK13, Kim YS14, Hur J15, Kim SW16.
Author information
1Kyungpook National University Hospital School of Medicine, Daegu, Korea.
2Inje University Busan Paik Hospital, Busan, Korea.
3Korea University Ansan Hospital College of Medicine, Seoul, Korea.
4Eulji University Hospital, Daejeon, Korea.
5Hanyang University Guri Hospital, Guri, Korea.
6Keimyung University Dongsan Medical Center, Daegu, Korea.
7Konyang University College of Medicine, Daejeon, Korea.
8Daegu Fatima Hospital, Daegu, Korea.
9Korea University College of Medicine, Seoul, Korea.
10Chonnam National University Hospital Medical School, Gwangju, Korea.
11Catholic University of Daegu School of Medicine, Daegu, Korea.
12Kyung Hee University School of Medicine, Seoul, Korea.
13Wonju Severance Christian Hospital, Wonju, Korea.
14Chungnam National University School of Medicine, Daejeon, Korea.
15Yeungnam University Medical Center, Daegu, Korea.
16Kyungpook National University Hospital School of Medicine, Daegu, Korea. Electronic address: [email protected].
Abstract
BACKGROUND:
Postexposure prophylaxis for occupational exposure to hepatitis B virus (HBV) plays an important role in the prevention of HBV infections in health care workers (HCWs). We examined data concerning the acceptable duration between occupational exposure and administration of a hepatitis B immunoglobulin (HBIG) injection in an occupational clinical setting.
METHODS:
A retrospective analysis was conducted with data from 143 cases of HCWs exposed to HBV in 15 secondary and tertiary teaching hospitals between January 2005 and June 2013. Data were taken from the infection control records of each hospital.
RESULTS:
Active vaccination after HBV exposure was started in 119 cases (83.2%) and postvaccination testing for hepatitis B antibody showed positive seroconversion in 93% of cases. In 98 cases (68.5%), HBIG was administered within 24 hours after HBV exposure; however, 45 HCWs (31.5%) received an HBIG injection more than 24 hours postexposure and 2 among the 45 received an injection after 7 days. Although 31.5% received an HBIG injection more than 24 hours postexposure, no cases of seroconversion to hepatitis b antibody positivity occurred.
CONCLUSIONS:
For susceptible HCWs, HBIG administered between 24 hours and 7 days postexposure may be as effective as administration within 24 hours in preventing occupational HBV infection.
Copyright © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
KEYWORDS:
Health care workers; Hepatitis B virus; Occupational exposure; Postexposure prophylaxis; Treatment outcomes
PMID:
26518500
[PubMed - as supplied by publisher]
|
|